Anna Skorupska

Ms. Anna Skorupska

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ASAnna Skorupska
Anna Skorupska
DBDominika Bystranowska
Dominika Bystranowska
KDKatarzyna Dąbrowska
Katarzyna Dąbrowska
AOAndrzej Ożyhar
Andrzej Ożyhar

Verified
Journal Article
Open access
PDF file
ASAnna Skorupska
Anna Skorupska
RLRafał Lenda
Rafał Lenda
AOAndrzej Ożyhar
Andrzej Ożyhar
DBDominika Bystranowska
Dominika Bystranowska
Nucb2 is a multifunctional protein associated with a variety of biological processes. Multiple studies have revealed that Nucb2, and its derivative nesfatin-1, are involved in carcinogenesis. Interestingly, the role of Nucb2/nesfatin-1 in tumorigenesis seems to be dual—both pro-metastatic and anti-metastatic. The implication of Nucb2/nesfatin-1 in carcinogenesis seems to be tissue dependent. Herein, we review the role of Nucb2/nesfatin-1 in both carcinogenesis and the apoptosis process, and we also highlight the multifaceted nature of Nucb2/nesfatin-1.

1 July 2000 in Antonie van Leeuwenhoek
Verified
Journal Article
Closed access
PDF file
MMMonika Marek-Kozaczuk
Monika Marek-Kozaczuk
JKJoanna Kopcińska
Joanna Kopcińska
BŁBarbara Łotocka
Barbara Łotocka
WGWładysław Golinowski
Władysław Golinowski
ASAnna Skorupska
Anna Skorupska

21 December 2018 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
ASAnna Skorupska
Anna Skorupska
AOAndrzej Ożyhar
Andrzej Ożyhar
DBDominika Bystranowska
Dominika Bystranowska
Nucleobindin-2 is a multidomain protein. Nucleobindin-2 can be cleaved into three peptide products: nesfatin-1, nesfatin-2 and nesfatin-3. It has been also shown that both Nucleobindin-2 and nesfatin-1 exhibit anorexigenic effect in rodents. In this review, we focused on a systematic characteristic of Nucleobindin-2, its anorexigenic effect and discussed possible mechanisms of its action. The first one is associated with melanocortin system and is leptin independent. The second – involves neurons that produce orexigenic neuropeptide Y. This has allowed integrating key findings which have important implications for treatment of obesity. We also presented Nucleobindin-2/nesfatin-1 as proteins which might become potentially important for understanding and treatment of such diseases as epilepsy, acute appendicitis or cancer. It has been shown that the Nucleobindin-2 function in cancerogenesis may be dual. The high level of Nucleobindin-2 and nesfatin-1 expression was found in colony, breast and endometrium cancer cells. Additionally, Nucleobindin-2/nesfatin-1 induced the proliferation process of these cells. In the future, Nucleobindin-2/nesfatin-1 may be used as a potential biomarker in diagnosis. However, Nucleobindin-2/nesfatin-1 inhibited ovarian and adrenocortical cancer cells proliferation and stimulated its apoptosis. The action of both proteins involved variety of metabolic pathways. The knowledge about activity control of Nucleobindin- 2/nesfatin-1 may contribute to new breakthrough in medicine.

29 June 2023 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
ASAnna Skorupska
Anna Skorupska
DBDominika Bystranowska
Dominika Bystranowska
JTJózef Ba Tran
Józef Ba Tran
AKArtur Krężel
Artur Krężel
AOAndrzej Ożyhar
Andrzej Ożyhar
Background: Nucleobindin-2 (Nucb2) is a multidomain protein that, due to its structure, participates in many physiological processes. It was originally identified in several regions of the hypothalamus. However, more recent studies have redefined and extended the function of Nucb2 far beyond its initially observed role as a negative modulator of food intake. Results: Previously, we described Nucb2 as structurally divided into two parts: the Zn2+-sensitive N-terminal half and the Ca2+-sensitive C-terminal half. Here, we investigated the structural and biochemical properties of its C-terminal half, which, after posttranslational processing, yields the formation of a fully uncharacterized peptide product known as nesfatin-3. Nesfatin-3 likely contains all the key respective structural regions of Nucb2. Hence, we expected that its molecular properties and affinity toward divalent metal ions might resemble those of Nucb2. Surprisingly, the obtained results showed that the molecular properties of nesftain-3 were completely different from those of its precursor protein. Moreover, we designed our work as a comparative analysis of two nesfatin-3 homologs. We noticed that in their apo forms, both proteins had similar shapes and existed in solution as extended molecules. They both interacted with divalent metal ions, and this interaction manifested itself in a compaction of the protein molecules. Despite their similarities, the differences between the homologous nesfatin-3s were even more informative. Each of them favored interaction with a different metal cation and displayed unique binding affinities compared either to each other or to Nucb2. Conclusions: The observed alterations suggested different from Nucb2 physiological roles of nesfatin-3 and different impacts on the functioning of the tissues and on metabolism and its control. Our results clearly demonstrated that nesfatin-3 possessed divalent metal ion binding properties, which remained hidden in the nucleobindin-2 precursor protein.